Free Newsletter
SPOTLIGHT: Deal or no deal for Lilly?
Free newsletter via e-mail
Tools
Remember the expert witness who leaked damaging documents about Zyprexa, Eli Lilly's schizophrenia med? He agreed to pay $100,000 to settle Lilly's lawsuit against him. But now the two are fighting over Lilly's' announcement of the deal because the company said he admitted breaking the law, but his lawyer says he admitted no such thing. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
SHARE
WITH: